Nathalie Wagner

Nathalie Wagner has extensive work experience in the field of clinical pharmacology and PK management. Nathalie recently served as the Head of Clinical Pharmacology at Galderma since December 2020. Prior to this role, they held positions such as Senior Clinical PK Manager and Global Clinical DMPK Manager and Project Leader at Galderma from 2019 to 2020 and 2014 to 2019, respectively. Nathalie has also worked as a Clinical DMPK Manager and ADME Team Leader in the preclinical department at Galderma, where they were responsible for various aspects of preclinical studies and PK analysis. Additionally, they have experience as a Non Clinical Pharmacokineticist at Galderma from 1990 to 1994. In 2013, Nathalie briefly served as the President of the French Association at GMP.

Nathalie Wagner's education history includes a DU (Diplôme Universitaire) in Pharmacocinétique from Universite Paul Sabatier in Toulouse, which they attained from 1994 to 1995. Prior to that, they obtained a maitrise degree in Physiology and Endocrinology from Universite de Nice, France, spanning from 1984 to 1988.